tiprankstipranks
Trending News
More News >
Lytix Biopharma AS (DE:6BG)
FRANKFURT:6BG
Germany Market

Lytix Biopharma AS (6BG) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
1Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Lytix Biopharma AS’s (6BG) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Lytix Biopharma AS is a Sell.
Lytix Biopharma AS’s (6BG) 20-Day exponential moving average is 0.55, while Lytix Biopharma AS’s (6BG) share price is €0.67, making it a Buy.
Lytix Biopharma AS’s (6BG) 50-Day exponential moving average is 0.48, while Lytix Biopharma AS’s (6BG) share price is €0.67, making it a Buy.

Lytix Biopharma AS (6BG) Pivot Points

May 25, 2025, 11:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.71
0.71
0.71
0.71
0.71
0.71
0.71
Fibonacci
0.71
0.71
0.71
0.71
0.71
0.71
0.71
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lytix Biopharma AS (6BG) Moving Averages

May 25, 2025, 11:55 PM
Period
Simple
Exponential
MA5
0.68Sell
0.66Buy
MA10
0.59Buy
0.61Buy
MA20
0.51Buy
0.55Buy
MA50
0.45Buy
0.48Buy
MA100
0.45Buy
0.48Buy
MA200
0.54Buy
0.54Buy
Lytix Biopharma AS’s (6BG) 10-Day exponential moving average is 0.61, while Lytix Biopharma AS’s (6BG) share price is €0.67, making it a Buy.
Lytix Biopharma AS’s (6BG) 100-Day exponential moving average is 0.48, while Lytix Biopharma AS’s (6BG) share price is €0.67, making it a Buy.
Lytix Biopharma AS’s (6BG) stock price is €0.67 and Lytix Biopharma AS’s (6BG) 50-day simple moving average is 0.45, creating a Buy signal.
Lytix Biopharma AS’s (6BG) stock price is €0.67 and Lytix Biopharma AS’s (6BG) 100-day simple moving average is 0.45, creating a Buy signal.
Lytix Biopharma AS’s (6BG) stock price is €0.67 and Lytix Biopharma AS’s (6BG) 200-day simple moving average is 0.54, creating a Buy signal.

Lytix Biopharma AS (6BG) Technical Indicators

May 25, 2025, 11:55 PM
Name
Value
Implied Action
RSI (14)
75.28
Sell
STOCH (9,6)
94.37
Sell
STOCHRSI (14)
94.45
Sell
MACD (12,26)
0.07
Sell
ADX (14)
36.35
Neutral
Williams %R
-15.21
Sell
CCI (14)
108.33
Sell
ATR (14)
0.02
-
Ultimate Oscillator
80.26
Buy
ROC
52.27
Buy
Lytix Biopharma AS’s (6BG) Relative Strength Index (RSI) is 75.28, creating a Sell signal.
Lytix Biopharma AS’s (6BG) Trend Strength Indicator (ADX) is 36.35, creating a Neutral signal.
Lytix Biopharma AS’s (6BG) Commodity Channel Index (CCI) is 108.33, creating a Sell signal.
Lytix Biopharma AS’s (6BG) Price Rate of Change (ROC) is 52.27, creating a Buy signal.

FAQ

Is 6BG a Buy, Hold, or Sell?
Based on 6BG’s technical indicators, 6BG is a Buy.
    What is 6BG’s RSI (14)?
    6BG’s RSI (14) is 75.28, which suggests 6BG is a Sell.
      What is 6BG’s MACD?
      6BG’s MACD is 0.07, which suggests 6BG is a Sell.
        What is 6BG’s 5-day moving average?
        6BG’s 5-day moving average is 0.68, which suggests 6BG is a Sell.
          What is 6BG’s 20-day moving average?
          6BG 20-day moving average is 0.51, which suggests 6BG is a Buy.
            What is 6BG’s 50-day moving average?
            6BG’s 50-day moving average is 0.45, which suggests 6BG is a Buy.
              What is 6BG’s 200-day moving average?
              6BG’s 200-day moving average is 0.54, which suggests 6BG is a Buy.
                What is 6BG’s Williams % R (14)?
                6BG’s Williams % R (14) is -15.21, which suggests 6BG is a Sell.
                  What is 6BG’s CCI (14)?
                  6BG’s CCI (14) is 108.33, which suggests 6BG is a Sell.
                    What is the share price of Lytix Biopharma AS?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis